10
Participants
Start Date
April 5, 2018
Primary Completion Date
December 17, 2018
Study Completion Date
December 17, 2018
89Zr-Girentuximab
Single diagnostic injection on Day 0, followed by diagnostic scans on Days 3 and 7±1, as well as the whole body dosimetric imaging on Days 0, 1, 3 and 7±1
Radboud University, Nijmegen
Collaborators (1)
ABX CRO
OTHER
Telix Pharmaceuticals (Innovations) Pty Limited
INDUSTRY
Radboud University Medical Center
OTHER